|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/505 | (2006.01) |
| C07D 239/28 | (2006.01) | ||
| A61P 37/08 | (2006.01) |
| (11) | Number of the document | 2281563 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10011119.4 |
| Date of filing the European patent application | 2003-01-31 | |
| (97) | Date of publication of the European application | 2011-02-09 |
| (45) | Date of publication and mention of the grant of the patent | 2013-09-18 |
| (46) | Date of publication of the claims translation | 2014-01-27 |
| (30) | Number | Date | Country code |
| 353333 P | 2002-02-01 | US | |
| 353267 P | 2002-02-01 | US | |
| 399673 P | 2002-07-29 | US | |
| 434277 P | 2002-12-17 | US |
| (72) |
Singh, Rajinder, US
Argade, Ankush, US
Payan, Donald G., US
Molineaux, Susan, US
Holland, Sacha J., US
Clough, Jeffrey, US
Keim, Holger, US
Bhamidipati, Somasekhar, US
Sylvain, Catherine, US
Li, Hui, US
Rossi, Alexander B., US
|
| (73) |
Rigel Pharmaceuticals, Inc.,
1180 Veterans Boulevard, South San Francisco, CA 94080,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | 2,4-Pirimidinamino junginiai ir jų panaudojimas |
| 2,4-Pyrimidinediamine compounds and their uses |
| Payment date | Validity (years) | Amount | |
| 2022-01-03 | 347.00 EUR |